Brexanolone by Sage Therapeutics for Alcohol Dependence: Likelihood of Approval

Brexanolone is under clinical development by Sage Therapeutics and currently in Phase I for Alcohol Dependence.

Surfing the web too much? Study links problematic internet use to heightened ADHD symptoms

This meta-analysis reveals a significant association between problematic internet use (PIU) and symptoms of ADHD, particularly in adult males who are not clinically diagnosed. The

October 31, 2023

Medtronic’s closed-loop neuromodulation device cuts overstimulation in trial

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Medtronic’s closed-loop spinal cord stimulation

January 22, 2024

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to

August 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.